Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua M Thurman

Showing results (1-10 of 174) with videos related to

Pageof 18
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|February 21, 2018
A Patient with Hemolytic Uremic Syndrome and Kidney FailureJoshua M Thurman
Advances in Chronic Kidney Disease|June 20, 2020
Complement and the Kidney: An OverviewJoshua M Thurman
Blood|March 29, 2014
New anti-complement drugs: not so far awayJoshua M Thurman
Kidney International|February 27, 2021
Rhabdomyolysis and complement-once again, epithelial cells take center stageJoshua M Thurman
Kidney International Reports|February 24, 2025
Nearing the Finish Line: Steady Progress in the Development of Complement Inhibitors for Glomerular DiseaseJoshua M Thurman
Cellular & Molecular Immunology|July 7, 2015
Getting over our Immune-Complex - C5a receptor blockade is the answerJoshua M Thurman
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2014
Complement in kidney disease: core curriculum 2015Joshua M Thurman
Academic Medicine : Journal of the Association of American Medical Colleges|April 24, 2026
SabbaticalJoshua M Thurman
Clinical Journal of the American Society of Nephrology : CJASN|February 4, 2021
BLISS in the Treatment of Lupus NephritisJoshua M Thurman
Clinical Immunology (Orlando, Fla.)|October 27, 2006
Triggers of inflammation after renal ischemia/reperfusionJoshua M Thurman
Pageof 18

Showing results (1-10 of 174) with videos related to

Sort By:
Pageof 18
Clinical Journal of the American Society of Nephrology : CJASN|February 21, 2018
A Patient with Hemolytic Uremic Syndrome and Kidney FailureJoshua M Thurman
Advances in Chronic Kidney Disease|June 20, 2020
Complement and the Kidney: An OverviewJoshua M Thurman
Blood|March 29, 2014
New anti-complement drugs: not so far awayJoshua M Thurman
Kidney International|February 27, 2021
Rhabdomyolysis and complement-once again, epithelial cells take center stageJoshua M Thurman
Kidney International Reports|February 24, 2025
Nearing the Finish Line: Steady Progress in the Development of Complement Inhibitors for Glomerular DiseaseJoshua M Thurman
Cellular & Molecular Immunology|July 7, 2015
Getting over our Immune-Complex - C5a receptor blockade is the answerJoshua M Thurman
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2014
Complement in kidney disease: core curriculum 2015Joshua M Thurman
Academic Medicine : Journal of the Association of American Medical Colleges|April 24, 2026
SabbaticalJoshua M Thurman
Clinical Journal of the American Society of Nephrology : CJASN|February 4, 2021
BLISS in the Treatment of Lupus NephritisJoshua M Thurman
Clinical Immunology (Orlando, Fla.)|October 27, 2006
Triggers of inflammation after renal ischemia/reperfusionJoshua M Thurman
Pageof 18